About
Personalized, Stem-Cell Based Regenerative Medicine
Areas of Focus
Categories
Biologics & BiopharmaceuticalStem Cell & Cellular Therapy
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
105
By Phase
PHASE3: 1PHASE1/PHASE2: 5PHASE1: 1
By Status
ACTIVE_NOT_RECRUITING: 3RECRUITING: 2COMPLETED: 2
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
Today
Hover over trial bars to see details
Recent Trials
NCT07112443Lead Sponsor
A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia.
PHASE3Recruiting
12 participants
Started: Sep 2, 2025 · Completed: Jul 31, 2027
NCT06532253Lead Sponsor
Long-term Safety Trial with NVDX3
PHASE1/PHASE2Recruiting
15 participants
Started: Aug 22, 2024 · Completed: Mar 31, 2036
NCT05961956Lead Sponsor
Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis
PHASE1/PHASE2Active, not recruiting
5 participants
Started: Oct 12, 2023 · Completed: Nov 15, 2025
NCT05987033Lead Sponsor
Proof-of-concept Study with NVDX3 for Treatment of Distal Radius Fractures.
PHASE1/PHASE2Completed
10 participants
Started: Aug 8, 2023 · Completed: Dec 19, 2024
NCT05693558Lead Sponsor
NVD-003 in the Treatment of Congenital Pseudarthrosis of the Tibia
PHASE1Active, not recruiting
4 participants
Started: Nov 24, 2022 · Completed: Jan 31, 2026
Locations (1)
Headquarters
Mont-Saint-Guibert, Belgium
Map
Loading map...